Position in SIGA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$183,503
-$90,106 QoQ
Shares Held
50,413
-1.4% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 160 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in SIGA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. SIGA ranks #39 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,437,213 | $103,278,126 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
120,078 | $65,061,862 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
312,832 | $52,724,705 | |
| 4 | VTRS |
Viatris Inc
|
2,872,464 | $45,614,728 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,264,159 | $31,110,952 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
633,778 | $21,973,083 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
197,060 | $21,861,836 | |
| 8 | ALKS |
Alkermes plc.
|
387,999 | $20,331,147 |
All Filings in SIGA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $183,503 | 50,413 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $273,609 | 51,142 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $327,709 | 53,635 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $588,683 | 64,337 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $443,920 | 68,086 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $370,749 | 67,655 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $403,385 | 67,119 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $458,736 | 67,961 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $530,897 | 69,947 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $574,341 | 67,096 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $373,195 | 66,642 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $352,884 | 67,216 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $344,450 | 68,208 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $361,818 | 62,925 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $445,780 | 60,568 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $613,220 | 59,536 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $638,451 | 55,134 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $365,865 | 51,603 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $395,589 | 52,605 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $395,365 | 53,500 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $333,712 | 53,139 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $388,206 | 59,724 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $460,074 | 63,284 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $413,395 | 60,174 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $414,816 | 70,189 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $327,860 | 68,590 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||